Maria H Rahmandar

Dr. Maria H Rahmandar

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Pediatrics
Verified
Journal Article
Closed access
MTMaria Trent
Maria Trent
DDDanielle G. Dooley
Danielle G. Dooley
JDJacqueline Dougé
Jacqueline Dougé
RCRobert M. Cavanaugh
Robert M. Cavanaugh
ALAmy E. Lacroix
Amy E. Lacroix
SWStephenie B. Wallace
Stephenie B. Wallace
This Policy Statement was reaffirmed August 2025.: The American Academy of Pediatrics is committed to addressing the factors that affect child and adolescent health with a focus on issues that may leave some children more vulnerable than others. Racism is a social determinant of health that has a profound impact on the health status of children, adolescents, emerging adults, and their families. Although progress has been made toward racial equality and equity, the evidence to support the continued negative impact of racism on health and well-being through implicit and explicit biases, institutional structures, and interpersonal relationships is clear. The objective of this policy statement is to provide an evidence-based document focused on the role of racism in child and adolescent development and health outcomes. By acknowledging the role of racism in child and adolescent health, pediatricians and other pediatric health professionals will be able to proactively engage in strategies to optimize clinical care, workforce development, professional education, systems engagement, and research in a manner designed to reduce the health effects of structural, personally mediated, and internalized racism and improve the health and well-being of all children, adolescents, emerging adults, and their families.

1 February 2019 in Pediatrics
Verified
Journal Article
Closed access
PDF file
BJBrian P. Jenssen
Brian P. Jenssen
SWSusan C. Walley
Susan C. Walley
SCSection On Tobacco Control
Section On Tobacco Control
JGJudith A. Groner
Judith A. Groner
MRMaria H Rahmandar
Maria H Rahmandar
ACAlice Little Caldwell
Alice Little Caldwell
This Policy Statement was reaffirmed August 2025.: Electronic cigarettes (e-cigarettes) are the most commonly used tobacco product among youth. The 2016 US Surgeon General’s Report on e-cigarette use among youth and young adults concluded that e-cigarettes are unsafe for children and adolescents. Furthermore, strong and consistent evidence finds that children and adolescents who use e-cigarettes are significantly more likely to go on to use traditional cigarettes—a product that kills half its long-term users. E-cigarette manufacturers target children with enticing candy and fruit flavors and use marketing strategies that have been previously successful with traditional cigarettes to attract youth to these products. Numerous toxicants and carcinogens have been found in e-cigarette solutions. Nonusers are involuntarily exposed to the emissions of these devices with secondhand and thirdhand aerosol. To prevent children, adolescents, and young adults from transitioning from e-cigarettes to traditional cigarettes and minimize the potential public health harm from e-cigarette use, there is a critical need for e-cigarette regulation, legislative action, and counterpromotion to protect youth.

1 December 2014 in Pediatrics
Verified
Journal Article
Open access
PDF file
MRMaria H Rahmandar
Maria H Rahmandar
ABAmanda Bawcom
Amanda Bawcom
MRMary E. Romano
Mary E. Romano
RHRizwan Hamid
Rizwan Hamid
Although cobalamin (cbl) C deficiency is the most common inherited disorder of vitamin B12 metabolism, the late-onset form of the disease can be difficult to recognize because it has a broad phenotypic spectrum. In this report, we describe an adolescent female exposed to unknown illicit substances and sexual abuse who presented with psychosis, anorexia, seizures, and ataxia. The patient’s diagnosis was delayed until a metabolic workup was initiated, revealing hyperhomocysteinemia, low normal plasma methionine, and methylmalonic aciduria. Ultimately, cblC deficiency was confirmed when molecular testing showed compound heterozygosity for mutations (c.271dupA and c.482G>A) in the MMACHC gene. This diagnosis led to appropriate treatment with hydroxocobalamin, betaine, and folate, which resulted in improvement of her clinical symptoms and laboratory values. This patient demonstrates a previously unrecognized presentation of late-onset cblC deficiency. Although neuropsychiatric symptoms are common in late-onset disease, seizures and cerebellar involvement are not. Furthermore, anorexia has not been previously described in these patients. This case emphasizes that inborn errors of metabolism should be part of the differential diagnosis for a teenager presenting with altered mental status, especially when the diagnosis is challenging or neurologic symptoms are unexplained. Correct diagnosis of this condition is important because treatment is available and can result in clinical improvement.1

4 May 2022 in Current Problems in Pediatric and Adolescent Health Care
Verified
Journal Article
Closed access
MRMaria H Rahmandar
Maria H Rahmandar
VGValerie Gribben
Valerie Gribben

25 May 2020 in Substance Abuse Treatment, Prevention, and Policy
Verified
Journal Article
Open access
PDF file
LKLisa Kuhns
Lisa Kuhns
BCBrookley Carlino
Brookley Carlino
KGKatie Greeley
Katie Greeley
AMAbigail L. Muldoon
Abigail L. Muldoon
NKNiranjan Karnik
Niranjan Karnik
MRMaria H Rahmandar
Maria H Rahmandar
Background: Despite recent reductions, youth substance use continues to be a concern in the United States. Structured primary care substance use screening among adolescents is recommended, but not widely implemented. The purpose of this study was to describe the distribution and characteristics of adolescent substance use screening in outpatient clinics in a large academic medical center and assess related factors (i.e., patient age, race/ethnicity, gender, and insurance type) to inform and improve the quality of substance use screening in practice. Methods: We abstracted a random sample of 127 records of patients aged 12–17 and coded clinical notes (e.g., converted open-ended notes to discrete values) to describe screening cases and related characteristics (e.g., which substances screened, how screened). We then analyzed descriptive patterns within the data to calculate screening rates, characteristics of screening, and used multiple logistic regression to identify related factors. Results: Among 127 records, rates of screening by providers were 72% (each) for common substances (alcohol, marijuana, tobacco). The primary method of screening was use of clinical mnemonic cues rather than standardized screening tools. A total of 6% of patients reported substance use during screening. Older age and racial/ethnic minority status were associated with provider screening in multiple logistic regression models. Conclusions: Despite recommendations, low rates of structured screening in primary care persist. Failure to use a standardized screening tool may contribute to low screening rates and biased screening. These findings may be used to inform implementation of standardized and structured screening in the clinical environment. Clinical trial registration: not applicable.

1 April 2021 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
MRMaria H Rahmandar
Maria H Rahmandar
FWFaith Summersett Williams
Faith Summersett Williams
LKLisa M. Kuhns
Lisa M. Kuhns
Opioid use disorders continue at epidemic proportions in the US. There is growing evidence that youths exposed to opioids for legitimate medical purposes have a